Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

The deal could expand access to its in-demand obesity drug at the expense of Eli Lilly, whose shares fell by double digits on ...

As GI conditions consume an increasing share of health care costs, employers must take proactive steps to manage expenses and ...

President Trump issued an Executive Order instructing federal agencies to implement a variety of drug pricing reforms.

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Eli Lilly & Co.’s shares fell 6% early Thursday after the drugmaker cut its full-year earnings outlook citing research costs ...

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

Experts urge for technology-driven, collaborative solutions as patients shoulder a growing burden of prescription costs.

NBC News' Berkeley Lovelace reports on the practicality of top health officials' suggestion that Americans take fewer medications in order to bring down national drug costs.

Many Medicare recipients are benefiting from changes that make prescriptions more affordable. But you can still make other ...